National and Kapodistrian University of Athens-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2024

  1. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

    Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221

2022

  1. Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 7

2019

  1. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673

2018

  1. Spatially resolved and quantitative analysis of vista/pd-1h as a novel immunotherapy target in human non–small cell lung cancer

    Clinical Cancer Research, Vol. 24, Núm. 7, pp. 1562-1573